Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Maher Saifo"'
Publikováno v:
Journal of Medical Case Reports, Vol 18, Iss 1, Pp 1-5 (2024)
Abstract Background Breast cancer is the most common cancer in women. Progression-free survival for hormone receptor-positive/human epidermal growth factor receptor-2-negative metastatic breast cancer treated with endocrine therapy in combination wit
Externí odkaz:
https://doaj.org/article/22f8c3121cd24a848570b640a455bd4c
Publikováno v:
Biomarker Insights, Vol 19 (2024)
Background: Tumor-induced coagulation is widely observed in cancer patients. Moreover, it is associated with tumorigenesis, tumor progression and metastasis, by creating a proliferative and proangiogenic microenvironment. Therefore, D-dimer, a fibrin
Externí odkaz:
https://doaj.org/article/fc121e667bd04b9fb8a477c938526fa5
Publikováno v:
Heliyon, Vol 10, Iss 19, Pp e38704- (2024)
Background: Epithelioid hemangioendothelioma (EHE) is an extremely rare vascular tumor that accounts for less than 1 % of all vascular tumors. The diagnosis of primary hepatic epithelioid hemangioendothelioma (HEHE) can be challenging because it may
Externí odkaz:
https://doaj.org/article/2bf6e16a372541fa80f02e879d713606
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundAdvanced breast cancer (ABC) is a heterogeneous disease with varied prognoses, that is affected by many clinicopathological features. This study aimed to investigate the clinicopathological characteristics, first-line treatment (FLx), and p
Externí odkaz:
https://doaj.org/article/63d23351c40c468f86fd292e18e1850e
Publikováno v:
Heliyon, Vol 10, Iss 15, Pp e35312- (2024)
Introduction: Breast cancer (BC) is the leading cause of death in Syria. In young females, it is a serious complication, making it crucial to raise awareness about the disease and its early detection methods. Given the challenging circumstances that
Externí odkaz:
https://doaj.org/article/d4eab2a1721045689a6ddc5c7836c6a5
Publikováno v:
Egyptian Journal of Medical Human Genetics, Vol 25, Iss 1, Pp 1-7 (2024)
Abstract Background Breast cancer (BC) is the most common female cancers in many countries including Syria. Familial breast cancer or previous family cancer history are considered significant risk factors. Therefore, detecting the prevalence and foun
Externí odkaz:
https://doaj.org/article/163e0cb362914c58af045d77f5e60b87
Autor:
Mohammed Alshafie, Jameel Soqia, Dima Alhomsi, Mhd Basheer Alameer, Laila Yakoub - Agha, Maher Saifo
Publikováno v:
BMC Women's Health, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background Breast cancer (BC) represents an important cause of cancer death, its incidence rate has been rising gradually in the Arab world, and in Syria, BC is the most common cancer and the leading cause of cancer death; its prognosis gets
Externí odkaz:
https://doaj.org/article/5b6f845ab1044f84afd421616ca1c1ce
Autor:
Fouad Nahhat, Modar Doyya, Kareem Zabad, Tarek Abo Laban, Hasan Najjar, Maher Saifo, Firas Badin
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-7 (2023)
Abstract Background The Syrian decade-long war has severely affected the healthcare system, including almost vanishing cancer screening practices, war-destroyed medical facilities, and lack of continuous medical education. This study aims to present
Externí odkaz:
https://doaj.org/article/848158bde5dd4a9787220b12fedf0c14
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionPolymorphisms in NUDT15 may result in differences in mercaptopurine-induced toxicity. This study aimed to identify the frequency of the NUDT15 (c.415C>T; rs116855232) polymorphism and investigate the effect of this polymorphism on mercapt
Externí odkaz:
https://doaj.org/article/5f79fb77ffb04e4aac846e4dfb5f426c
Autor:
Mousa Alali, Maher Saifo
Publikováno v:
Journal of Immunotherapy and Precision Oncology, Vol 6, Iss 3, Pp 140-149 (2023)
Introduction: Osimertinib is the treatment of choice for epidermal growth factor receptor (EGFR)-mutated advanced non–small-cell lung cancer (NSCLC). Because of its high price, many low-income countries, such as Syria, cannot provide osimertinib, w
Externí odkaz:
https://doaj.org/article/3c4a12854f7440fda5499bdf9f3860e0